K-convenience chains gain momentum overseas with private labels
CU, GS25 divesifiy exclusive snack and dessert lines to meet global appetite for K-food
South Korea's convenience store chains, led by industry frontrunners CU and GS25, are making bigger waves globally, riding the K-food boom with their exclusive products.
GS25, the country's largest convenience store brand by sales, is solidifying its presence in overseas markets with its YouUs private-label products and exclusive offerings at the forefront.
Strategic partnerships — most notably a collaboration with Netflix to create Squid Game-inspired snacks — have also played a key role in driving this momentum.
'Korean convenience stores, with savvy marketing strategies, have become hubs for showcasing the latest Korean food trends abroad,' said an industry official, explaining the expansion momentum behind the convenience chains.
Reaching 30 countries across Asia, Africa, North America, the Middle East and Europe, GS25's operator GS Retail saw its export revenue soar to $9 million last year, up from $3.4 million in 2020.
Beyond its expanding export volume, GS25 has been cementing a strong physical presence abroad, operating 355 stores in Vietnam and 270 in Mongolia as of January.
'We plan to broaden our product lineup with K-desserts while expanding into new markets through retail partnerships, including those for Halal food products,' said a GS Retail official.
GS25's archrival CU is also bearing fruits from its overseas push.
Export volume of BGF Retail, the operator of CU, shot up to $8 million last year, up 23 percent from $6.5 million in 2021.
Driving its export growth is a diverse lineup of food products under CU's private brand, Heyroo, which reaches over 20 countries, including the US, China, the UK and the Netherlands. It also boasts exclusive products like the popular Yonsei Milk Cream Bread, a standout favorite among CU offerings.
Last year, CU became the first Korean convenience store chain to secure a dedicated display for 15 of its private-label products at Japan's largest discount retailer, Don Quijote.
For CU, Mongolia leads the way with 460 stores, followed by Malaysia with 150 and Kazakhstan with 30, as of February. According to a CU official, its proprietary products account for approximately 50 percent of total sales at its international locations.
'CU-exclusive products like Yonsei Milk Cream Bread are flying off the shelves in Mongolia, while in Malaysia, Korean-style fried chicken and tteokbokki rank among the top-selling products,' the official said.
The global scope of convenience store chains is extending even further, with growth plans gaining momentum in the years ahead.
CU targets 500 outposts in Mongolia by this year, another 500 in Malaysia by 2028 and 500 more in Kazakhstan by 2029. Meanwhile, GS25 is picking up speed, setting its sights on hitting 1,500 international locations by 2027.
Korean food exports have been on a steady upward trajectory over the past decade. According to the Korea Trade Statistics Promotion Institute, K-food exports surged from $3.51 billion in 2015 to $7.02 billion in 2024, with an annual growth rate of 8 percent.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Korea Herald
29 minutes ago
- Korea Herald
Korean biopharma firms gear up for record presence at BIO USA 2025
Samsung Biologics to showcase CDMO scale-up, digital transformation with largest Korean booth Korean pharmaceutical and biotechnology companies are gearing up for a strong presence at the 2025 BIO International Convention (BIO USA), one of the world's largest biopharma exhibitions, which will take place in Boston starting June 16. Organized annually by the Biotechnology Innovation Organization, BIO USA rotates among major US biotech hubs and serves as a premier global platform for industry leaders to explore strategic partnerships and collaborations. This year's convention, held under the theme 'The World Can't Wait,' will run from June 16 to 19 at the Boston Convention & Exhibition Center. The event is expected to draw more than 9,000 companies from 88 countries and over 20,000 professionals from across the biopharma sector. Roughly 80 Korean companies and organizations will participate by setting up booths. Samsung Biologics Samsung Biologics, one of the largest exhibitors, will mark its 13th consecutive year taking part in the event. It will set up a 167-square-meter booth at the entrance of the exhibition hall — the area with the highest foot traffic — to maximize visibility and draw visitor attention. The booth will showcase the company's expanding contract development and manufacturing organization capabilities through high-tech features such as an LED display wall and interactive touchscreens. These elements are designed to communicate Samsung's advanced service offerings with a strong emphasis on digital transformation in biopharma. Highlights will include a comprehensive look at Samsung Biologics' latest advancements, such as the recent launch of its fifth manufacturing plant, boosting its total production capacity to 784,000 liters — among the highest in the world. The company will also spotlight its capabilities in multi-specific antibody development, its newly introduced antibody-drug conjugate services and AI-driven operational systems, all of which support its goal of becoming a global top-tier CDMO. Other leading Korean CDMO and CMO firms — Celltrion, SK Biopharmaceuticals and Lotte Biologics — will also be attending, competing for new contracts against major players from the US, China and Japan. Celltrion, participating for the 16th year, will operate its own booth to promote products and engage with potential partners, while SK Biopharmaceuticals plans to focus on increasing global brand recognition through a series of high-level business development meetings. Lotte Biologics will showcase its ADC production facilities at the Syracuse Bio Campus and unveil the development roadmap for its Songdo Bio Campus Plant 1, scheduled to begin commercial operations in 2027. Although Daewoong Pharmaceutical and Hanmi Pharmaceutical will not operate a booth at the event, they will participate through business meetings, aiming to strengthen their global presence by showcasing ongoing research and development efforts in new drug discovery. The Cha Vaccine Institute will use the event to promote its shingles (CVI-VZV-001) and hepatitis B (CVI-HBV-002) vaccines, focusing on licensing and joint development opportunities. The institute aims to build partnerships across Southeast Asia, the Middle East, Europe and Latin America to explore co-development and tech transfer prospects. The Cha Vaccine Institute will also participate in the company presentation sessions and the Korea Pavilion pitching event, where it will outline its research pipelines and market strategies. 'We will introduce our proprietary adjuvant platform and vaccine development capabilities at BIO USA, aiming to turn this exposure into real business outcomes,' said Yeom Jeong-seon, CEO of the Cha Vaccine Institute. Meanwhile, Korea BIO will play a significant role at the convention. The Korea Pavilion will feature a record 51 Korean companies, and Korea BIO will facilitate discussions with the US BIO association on key issues, including customs regulations, drug pricing and supply chain resilience, while also providing a partnering platform for domestic companies. According to an industry insider, Korea stands to benefit significantly from shifting global dynamics at this year's BIO USA. 'As US-China tensions reshape the global biotech supply chain, Korean firms that can quickly adapt to geopolitical shifts are well-positioned to secure major deals. Their strong technological base and aggressive manufacturing scale-up efforts make them attractive alternatives to Chinese firms facing regulatory hurdles, potentially positioning Korea as a central beneficiary in the new global order,' the official said, on condition of anonymity.
Korea Herald
29 minutes ago
- Korea Herald
Lee signals major stimulus to revive growth, fight inflation
Second supplementary budget expected to exceed W20tr, with focus on AI, industrial upgrades Korean President Lee Jae-myung ordered immediate measures to curb rising food prices on Monday, signaling his administration's intent to roll out fiscal stimulus to revive growth and fulfill his campaign pledge of raising the country's potential GDP growth to 3 percent. 'The people are suffering greatly because of rising prices,' Lee said while presiding over a meeting of his emergency economic task force in Yongsan, Seoul. 'I've heard prices have gone up significantly. Is it true that a single packet of ramyeon now costs 2,000 won ($1.50)?' Less than a week into his term, the newly inaugurated president faces the twin challenges of easing cost-of-living pressures and stimulating an economy mired in weak domestic demand. While headline inflation fell to 1.9 percent in May, its lowest in five months, thanks to declining global oil prices, food costs remain elevated. Prices for processed foods, including staples such as bread, chocolate, ramyeon, coffee and frozen food, jumped 4.1 percent from a month earlier, according to Statistics Korea. Vice Finance Minister Kim Beom-seok warned that prices for eggs and chicken could spike 'if we don't respond properly," due to an outbreak of highly pathogenic bird flu in Brazil, a key exporter of boneless chicken to Korea. Analysts say food companies held off on price hikes earlier this year in cooperation with the previous government, but began raising prices en masse during the political vacuum triggered by former President Yoon Suk Yeol's impeachment. Lee's emergency task force, established via executive order on his first day in office, June 4, held its second meeting Monday, bringing together economic aides; key ministers from the economy, industry and infrastructure portfolios; and officials from the Financial Services Commission. It was expected that the size of the second extra budget would be revealed at the meeting, but the government deferred the announcement. To achieve the administration's 3 percent potential GDP growth target, above the OECD's 2.02 percent forecast for 2025 and the Bank of Korea's 2 percent range for 2024-2026, the government is expected to rely on two main pillars: a second supplementary budget, and major investments in emerging industries such as artificial intelligence, paired with structural reforms to enhance industrial competitiveness. The ruling Democratic Party of Korea signaled the additional budget will total between 20 and 21 trillion won, following the 13.8 trillion won supplementary budget passed in May to support disaster recovery and bolster industries affected by US tariff tensions. 'Amid an unprecedented domestic demand slump, small business owners and the self-employed are on the brink of collapse,' said Democratic Party spokesperson Rep. Jo Seoung-lae. 'We urge the opposition to actively cooperate in the prompt passage of the supplementary budget to protect the people's livelihoods.' Investor sentiment appears to be shifting. Global banks are revising their growth outlooks for Korea upward from previously pessimistic projections. Barclays recently raised its 2025 GDP forecast from 0.9 percent to 1.0 percent, citing the likelihood of expansionary fiscal policy regardless of political leadership. Goldman Sachs increased its projection from 0.7 percent to 1.1 percent, estimating that a second supplementary budget equal to 1 percent of GDP could lift this year's growth by 0.3 percentage points. Citigroup economist Kim Jin-wook expects the upcoming stimulus package, estimated to be between 20 trillion and 35 trillion won, to boost total Korean Treasury Bond issuance for 2025 to between 227.1 trillion and 242.1 trillion won, significantly above the 2020–2024 average of 169.5 trillion won. 'Given the limited room for excess tax revenue and public funds, the second extra budget will likely be financed mostly through additional net treasury bond issuance,' Kim said.
Korea Herald
an hour ago
- Korea Herald
Battery makers push President Lee for direct subsidies
Korean firms seek bolder funding as Chinese rivals leverage robust government backing South Korean battery manufacturers are urging President Lee Jae-myung to act as they face slowing electric vehicle demand and intensifying competition from Chinese rivals increasingly dominating global markets. On May 31, three days before the presidential election, Lee wrote in a Facebook post, 'I will recharge the South Korean economy with K-batteries,' underscoring his belief that the battery industry is key to driving Korea's next economic leap. Lee's pledges included strengthening research and development to secure cutting-edge technologies such as all-solid-state batteries; introducing domestic production tax incentives; creating a "battery triangle belt" connecting the Chungcheong, Yeongnam, and Honam regions; increasing battery demand through energy storage systems; and nurturing the battery recycling industry. Calls for IRA-style subsidies While industry insiders are optimistic about the domestic tax incentives, they anticipate a more direct form of financial support from the government. Lee's tax benefit pledge offers tax breaks for companies producing and selling battery products in Korea, similar to the US Advanced Manufacturing Production Credit under the Inflation Reduction Act. However, AMPC also includes options like 'cash refunds' and 'third-party transfers' in addition to tax benefits. 'If we could receive cash returns, we'd have more flexibility to expand investments in global markets — particularly in the US, where rising tariffs on automobiles and parts are already dragging down the EV market,' said an industry source on condition of anonymity. The source emphasized that additional support measures are needed, pointing out that unlike China, which offers subsidies from direct funding to state-led R&D programs, the Korean government has only granted corporate tax credits. Under the Act on Restriction on Special Cases Concerning Taxation, the battery industry is designated a national strategic technology, making it eligible for approximately 15 percent and 30 percent tax credits on facility investments and R&D, respectively. However, these credits apply only to companies that are generating taxable profits. In the first quarter, Korea's top three battery makers — LG Energy Solution, Samsung SDI, and SK On — all reported operating losses, even when factoring in benefits from AMPC. As a result, they are likely ineligible for domestic tax breaks, despite having collectively borrowed 49.6 trillion won ($36.5 billion) for large-scale investments both at home and abroad. Chinese surge Experts suggest that even with the battery sector's strategic importance, direct subsidies from the Korean government remain unlikely. 'Korea has traditionally been wary of direct funding due to the associated risks and concerns over misusing taxpayer money,' said Kim De-jong, a business professor at Sejong University. 'In contrast, while China provides massive subsidies, it often gains substantial control over the company's management and operations.' Kim added that more feasible alternatives to direct subsidies could include offering discounted rates on electricity and water for domestic production facilities. Meanwhile, Chinese battery giants CATL and BYD have strengthened their grip on the global EV market. According to SNE Research, CATL and BYD held market shares of 38.1 percent and 17.3 percent, respectively, as of the latest period, up from the previous year. LG Energy Solution ranked third but saw its share fall from 12.3 percent to 10.2 percent. SK On and Samsung SDI also experienced declines, with market shares dropping to 4.3 percent and 3.3 percent, respectively.
